Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
53.20B | 55.05B | 68.26B | 62.28B | 44.34B | 47.46B | Gross Profit |
16.26B | 18.00B | 24.48B | 19.34B | 11.65B | 14.77B | EBIT |
1.04B | 3.16B | 9.46B | 5.90B | -559.00M | 1.34B | EBITDA |
4.56B | 8.48B | 12.88B | 9.78B | 3.27B | 5.14B | Net Income Common Stockholders |
415.00M | 2.67B | 7.47B | 4.13B | 215.00M | -185.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
21.72B | 19.77B | 18.85B | 18.00B | 15.49B | 12.92B | Total Assets |
121.63B | 119.19B | 114.35B | 107.08B | 100.95B | 98.12B | Total Debt |
33.65B | 32.71B | 22.12B | 23.86B | 29.22B | 28.05B | Net Debt |
11.93B | 13.73B | 3.27B | 5.86B | 13.73B | 15.12B | Total Liabilities |
45.35B | 43.02B | 42.69B | 43.11B | 41.52B | 40.68B | Stockholders Equity |
76.28B | 76.16B | 71.66B | 63.97B | 59.42B | 57.44B |
Cash Flow | Free Cash Flow | ||||
0.00 | -7.50B | 4.06B | 8.29B | 2.55B | -8.73B | Operating Cash Flow |
0.00 | -2.49B | 6.40B | 10.27B | 5.66B | -2.50B | Investing Cash Flow |
0.00 | -5.30B | -2.70B | -2.10B | -3.01B | -6.19B | Financing Cash Flow |
0.00 | 7.57B | -3.35B | -6.44B | -412.00M | 4.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.90T | 13.74 | 13.37% | 2.04% | 10.79% | 35.98% | |
73 Outperform | ¥870.19B | 14.56 | 8.10% | 1.97% | 7.44% | -5.08% | |
68 Neutral | ¥365.55B | 28.46 | 1.72% | 4.24% | -0.38% | -65.61% | |
64 Neutral | $4.36B | 12.05 | 5.23% | 249.94% | 4.13% | -10.23% | |
58 Neutral | ¥35.05B | 34.86 | 3.92% | -8.70% | -89.31% | ||
57 Neutral | €119.18B | 30.58 | -2.10% | 4.97% | 0.75% | -128.63% | |
52 Neutral | ¥289.92B | 39.81 | 5.41% | -3.42% | -35.09% |